Sort
21,453 grants matching “tuberculosis”
Targeting NETosis for the Treatment of Tuberculosis
$629,631Christina Leigh Stallings · Washington University · R01 · FY2023 · AI
Supramolecular nanofiber vaccines
$629,583Joel H Collier · Duke University · R01 · FY2016 · AI
Development of novel anti-TB drugs that inhibit cell wall biosynthesis and respiration
$629,538David Alland · Hackensack University Medical Center · U19 · FY2023 · AI
Synthesis of Anti-Infective Agents
$629,515K. C. Nicolaou · Scripps Research Institute, The · R01 · FY2012 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$629,390Jyothi Rengarajan · Emory University · R01 · FY2017 · AI
Dynamics of TB and MDR TB transmission in areas with high HIV prevalence
$629,230Nicola Mario Zetola · University Of Pennsylvania · R01 · FY2011 · AI
PREVENTION, CONTROL AND ELIMINATION OF TUBERCULOSIS IN THE DISTRICT OF COLUMBIA
$629,220Nnemdi Kamanu-Elias · Dist Of Columbia Dept Of Hiv/Aids Admin · U52 · FY2012 · PS
Dynamics of the cellular and molecular architecture of human pulmonary TB granulomas
$629,213Robert L Modlin · University Of California Los Angeles · R01 · FY2025 · AI
Who are the Ultra-positive, culture-negative? Understanding the trajectories of individuals in Uganda with trace M. tuberculosis nucleic acid in sputum
$629,170Emily A Kendall · Johns Hopkins University · R01 · FY2023 · HL
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$629,119Douglas K Owens · Stanford University · R01 · FY2015 · DA
Mali Project (Serefo)
$629,087Michael L. Polis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
M. tuberculosis exosome detection for pediatric TB diagnosis
$629,073Sylvia Lacourse · University Of Washington · R01 · FY2023 · AI
M. tuberculosis strain-dependent interactions with host cells
$628,949Jeffery S Cox · University Of Washington · U19 · FY2023 · AI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$628,929Frederick Lewis Altice · Yale University · R01 · FY2020 · DA
Type II alveolar epithelial cell-intrinsic IL-1 response in protective immunity against tuberculosis
$628,698Bibhuti Bhusan Mishra · Albany Medical College · R01 · FY2024 · HL
Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs
$628,668Ian David Aronson · New York University · R01 · FY2023 · DA
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment
$628,640Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HL
CRIF:MU Establishment of a Cyber-Enabled Electron Spin Resonance Spectrometer Facility
$628,556Stephen F Martin · University Of Texas At Austin · · FY2007 · MPS
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$628,503Susan Jenkins · Missouri State Dept Of Social Services · U52 · FY2009 · PS
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$628,503Susan Jenkins · Missouri State Dept Of Social Services · U52 · FY2008 · PS
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
$628,385Zheng W Chen · University Of Illinois At Chicago · R01 · FY2016 · OD
Kaiser Washington Vaccine and Treatment Evaluation Unit
$628,365Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2023 · AI
MmpL3 as a target for novel anti-TB agents
$628,287Mary Jackson · Colorado State University · R01 · FY2024 · AI
MmpL3 as a target for novel anti-TB agents
$628,287Mary Jackson · Colorado State University · R01 · FY2023 · AI
MmpL3 as a target for novel anti-TB agents
$628,287Mary Jackson · Colorado State University · R01 · FY2022 · AI